. (2016). Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 18(12), 1199-1206. https://doi.org/10.1111/dom.12742 2 Abstract Aim: Given the conflicting evidence of sodium-glucose cotransporter 2 (SGLT2) inhibitors on bone health in patients with type 2 diabetes Mellitus (T2DM), we aimed to evaluate the comparative effects of SGLT2 inhibitors on risk of bone fracture.Methods: PubMed, EMBASE, CENTRAL, and ClinicalTrials.gov were systematically searched from inception to January 27, 2016 to identify RCTs reporting the outcome of fracture in T2DM patients with the use of SGLT2 inhibitors. A pairwise and network meta-analyses, as well as a cumulative meta-analysis were performed to calculate their odds ratios (ORs) and 95% confidence intervals (CIs).Results: A total of 38 eligible RCTs (10 canagliflozin, 15 dapagliflozin, and 13 empagliflozin) involving 30,384 patients with periods of follow-up ranged from 24 to 160 weeks were included. The fracture event rates were 1.59% in the SGLT2 inhibitor groups and 1.56% in the control groups. The incidence of fracture event was similar among these three SGLT2 inhibitor groups. Compared with placebo, canagliflozin (OR, 1.15; 95%CI, 0.71 to 1.88), dapagliflozin (OR, 0.68; 95%CI, 0.37 to 1.25), and empagliflozin (OR, 0.93; 95%CI, 0.74 to 1.18) was not significantly associated with an increased risk of fracture. Our cumulative meta-analysis indicated the robustness of our null findings of SGLT2 inhibitors. Conclusions:Our meta-analysis based on available RCT data does not support the harm effect of SGLT2 inhibitors on fracture, although future safety monitoring from RCT and real-world data with detailed information on bone health is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.